These data suggest compartmentalization of RAGE ligands in the airway lumen in patients with obstructive lung diseases, and may explain why we did not find any significant increase in the circulating levels of CML and S100A12 in our COPD sample. Here, AGER is linked to chronic myelogenous leukemia, BCR-ABL1 positive.